Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphoma.

BIOMED‐2 protocol FR3 complete IgH gene rearrangement diffuse large B‐cell lymphoma neoantigen

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 22 01 2024
revised: 24 04 2024
accepted: 26 04 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

Somatic hypermutations (SHMs) in the variable region (V

Identifiants

pubmed: 39157631
doi: 10.1002/jha2.921
pii: JHA2921
pmc: PMC11327714
doi:

Types de publication

Journal Article

Langues

eng

Pagination

698-708

Informations de copyright

© 2024 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Tomohiro Yabushita (T)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.
International Research Center for Medical Sciences Kumamoto University Kumamoto Japan.

Yoshimitsu Shimomura (Y)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.

Hayato Maruoka (H)

Department of Clinical Laboratory Kobe City Medical Center General Hospital Kobe Japan.

Daisuke Katoh (D)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.

Daisuke Yamashita (D)

Department of Pathology Kobe City Medical Center General Hospital Kobe Japan.

Hironaga Satake (H)

Department of Medical Oncology Kobe City Medical Center General Hospital Kobe Japan.
Department of Medical Oncology Kochi Medical School Kochi Japan.

Nobuhiro Hiramoto (N)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.

Satoshi Yoshioka (S)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.
Department of Hematology Japanese Red Cross Osaka Hospital Osaka Japan.

Noboru Yonetani (N)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.

Momoko Nishikori (M)

Department of Hematology and Oncology, Graduate School of Medicine Kyoto University Kyoto Japan.

Takeshi Morimoto (T)

Clinical Research Center Kobe City Medical Center General Hospital Kobe Japan.
Department of Clinical Epidemiology Hyogo College of Medicine Hyogo Japan.

Yukihiro Imai (Y)

Department of Pathology Kobe City Medical Center General Hospital Kobe Japan.
Department of Surgical Pathology Kakogawa Central City Hospital Kakogawa Japan.

Takayuki Ishikawa (T)

Department of Hematology Kobe City Medical Center General Hospital Kobe Japan.

Classifications MeSH